scholarly journals Lopsided Blood-thinning Drug Increases the Risk of Internal Flow Choking and Shock Wave Generation Causing Asymptomatic Stroke

2021 ◽  
Author(s):  
SANALKUMAR V R

An overdose of blood-thinning drug reduces blood viscosity (BV) and increases Reynolds number causing high-turbulence leading to the Sanal flow choking (PMCID: PMC7267099). Asymptomatic stroke could be diminished by concurrently lessening the BV and flow turbulence by rising thermal tolerance level in terms of biofluid/blood heat capacity ratio (BHCR) or by decreasing the blood pressure ratio (BPR). In conclusion, BPR must always be lower than 1.8257 as dictated by the lowest BHCR of the evolved gas (CO2) for prohibiting asymptomatic stroke.

Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Sanal Kumar V R ◽  

Introduction: Consequence of lopsided blood-thinning-drug, lowering blood-viscosity (BV), is bleeding and very frequently asymptomatic-hemorrhage (AH) and the acute-heart-failure (AHF) happen. V.R.S.Kumar et al. (2020) reported that such asymptomatic episodes are due to the internal flow choking in the cardiovascular system (CVS) at a critical blood pressure ratio (BPR), which is regulated by biofluid/blood heat capacity ratio (BHCR). Methods: The closed-form-analytical-methodology is used for correlating BV, BPR, BHCR, vessel geometry and ejection fraction (EF). In vitro method is used for the BHCR estimation of healthy subjects. In silico method is used for demonstrating the Sanal flow choking. Results: The analytical models reveal that the relatively high and low BV are risk factors of internal flow choking. In vitro study shows that N 2 , O 2 , CO 2 & Ar gases are predominant in fresh-blood samples of the healthy subjects at a temperature range of 37-40 0 C (98.6-104 0 F), which increases the risk of flow-choking. In silico results demonstrated the Sanal flow choking followed by the shock wave generation and pressure-overshoot in a simulated artery with the divergent/bifurcation region. Conclusions: An overdose of blood-thinning drug reduces BV and increases Reynolds number causing high-turbulence leading to the Sanal flow choking. Asymptomatic stroke could be diminished by concurrently lessening the BV and flow turbulence by rising thermal tolerance level in terms of BHCR or by decreasing the BPR. In conclusion, BPR must always be lower than 1.8257 as dictated by the lowest BHCR of the evolved gas (CO 2 ) for prohibiting asymptomatic stroke.


2021 ◽  
Author(s):  
SANALKUMAR V R

Lopsided Blood-thinning Drug Increases the Risk of Internal Flow Choking and Shock Wave Generation Causing Asymptomatic Stroke Author Block: V R SANAL KUMAR, ISRO; S.K.Choudhary, AIIMS; P.K.Radhakrishnan, GU; Suresh Menon, GT; Vrishank Raghav, AU; K.K.N Namboodiri, Sapna E.Sreedharan, SCTIMST; Bharath R.S, Nichith C, C.Oommen, IISc; V.Sankar, IITK; A.Sukumaran, KCT; Arun K, DHMMC; A.Pal, Tharikaa R.K, AU, Abhirami R, AIMS. IntroductionConsequence of lopsided blood-thinning-drug, lowering blood-viscosity (BV), is bleeding and very frequently asymptomatic-hemorrhage (AH) and the acute-heart-failure (AHF) happen. V.R.S.Kumar et al. (2020) reported that such asymptomatic episodes are due to the internal flow choking in the cardiovascular system (CVS) at a critical blood-pressure-ratio (BPR), which is regulated by biofluid/blood heat capacity ratio (BHCR). MethodsThe closed-form-analytical-methodology is used for correlating BV, BPR, BHCR, vessel geometry and ejection fraction (EF). In vitro method is used for the BHCR estimation of healthy subjects. In silico method is used for demonstrating the Sanal flow choking. ResultsThe analytical models reveal that the relatively high and low BV are risk factors of internal flow choking. In vitro study shows that N2, O2, CO2 & Ar gases are predominant in fresh-blood samples of the healthy subjects at a temperature range of 37-400 C (98.6-1040 F), which increases the risk of flow-choking. In silico results demonstrated the Sanal flow choking followed by the shock wave generation and pressure-overshoot in a simulated artery with the divergent/bifurcation region. ConclusionsAn overdose of blood-thinning drug reduces BV and increases Reynolds number causing high-turbulence leading to the Sanal flow choking. Asymptomatic stroke could be diminished by concurrently lessening the BV and flow turbulence by rising thermal tolerance level in terms of BHCR or by decreasing the BPR. In conclusion, BPR must always be lower than 1.8257 as dictated by the lowest BHCR of the evolved gas for prohibiting asymptomatic stroke.


2021 ◽  
pp. 2000076
Author(s):  
Valsalayam Raghavapanicker Sanal Kumar ◽  
Shiv Kumar Choudhary ◽  
Pradeep Kumar Radhakrishnan ◽  
Rajaghatta Sundararam Bharath ◽  
Nichith Chandrasekaran ◽  
...  

2021 ◽  
Author(s):  
SANAL KUMAR V R ◽  
Shiv Kumar Choudhary ◽  
Pradeep Kumar Radhakrishnan ◽  
Bharath R.S. ◽  
Nichith Chandrasekaran ◽  
...  

Abstract BackgroundThe truly popular consequence of management with the blood-thinning-drug, causation of lower blood-viscosity (BV), is bleeding and very frequently asymptomatic-hemorrhage (AH) and the acute-heart-failure (AHF) happen without any preceding symptoms.ObjectivesOur aim was to develop an infallible closed-form analytical model for demonstrating the proof of the concept of the Sanal flow choking in cardiovascular system (CVS) causing AH and AHF by correlating the blood pressure ratio (BPR), biofluid/blood-heat-capacity-ratio(BHCR), blood viscosity(BV), stenosis (in terms of vessel cross-sectional area (VCA)) and ejection fraction(EF). For establishing the proof of the concept we were planned in vitro and in silico studies. MethodsThe closed-form-analytical-methodology is used herein to establish the proof of the concept of Sanal-flow-choking. In vitro method is invoked for the speciation analyses of blood samples of healthy subjects (human being/Guinea pig) for the BHCR estimation. In silico method is used for demonstrating the asymptomatic pressure-overshoot in an artery due to the Sanal flow choking and shock wave generation. ResultsThe closed-form analytical, in vitro and in silico results are presented herein to establish the proof of the concept of internal flow choking in CVS causing cardiovascular risk without prejudice to the percutaneous coronary intervention (PCI). The analytical models reveal that the relatively high and low BV are risk factors of AH and AHF. In vitro study shows that nitrogen(N2), oxygen(O2), carbon dioxide(CO2) and argon(Ar) gases are predominant in fresh-blood samples of the healthy human-being and Guinea-pig at a temperature range of 37-400 C (98.6-1040 F), which increases the risk of flow-choking leading to AH and AHF. The thermal-tolerance level in terms of BHCR of Guinea-pig is found higher than the human being. In silico results demonstrated the Sanal flow choking and shock wave generation in an artery with the divergent/bifurcation region. ConclusionsAn overdose of blood-thinning drug for reducing the blood-viscosity(BV) augments Reynolds number leading to high-turbulence and enhanced boundary-layer-blockage(BLB), which increases the chances of cavitation and the Sanal-flow-choking leading to the shock wave and pressure-overshoot causing memory effect (stroke history) in viscoelastic vessels. Designing the precise blood-thinning regimen is vital for attaining the desired therapeutic efficacy and negating undesirable flow-choking leading to AH and AHF. Herein we established that the disproportionate blood-thinning treatment increases the risk of the Sanal-flow-choking due to the enhanced BLB factor. The cardiovascular risk could be diminished by concurrently lessening the BV and flow turbulence by rising thermal-tolerance-level in terms of BHCR or by decreasing the BPR. Condensed AbstractHerein, we provide a proof of the concept to establish that such asymptomatic diseases are due to the boundary-layer-blockage (BLB) induced flow choking (Sanal-flow-choking) at a critical blood-pressure-ratio (BPR). When the pressure of the nanoscale-fluid increases, average-mean-free-path decreases and thus, the Knudsen number reduces leading to a no-slip boundary condition with compressible-viscous (CV) flow effect. Sanal-flow-choking is a CV flow effect creating a physical situation of the sonic-fluid-throat, at a critical BPR. We concluded that AH and AHF are transient-events due to flow-choking, and not an illness. The cardiovascular risk could be diminished by concurrently lessening the BV and flow turbulence by rising thermal-tolerance-level in terms of BHCR or by decreasing the BPR.


2021 ◽  
Author(s):  
V.R. Sanal Kumar ◽  
Nichith Chandrasekaran ◽  
Vigneshwaran Sankar ◽  
Ajith Sukumaran ◽  
Sivabalan Mani ◽  
...  

Abstract The theoretical finding of the Sanal-flow-choking [PMCID: PMC7267099] and streamtube flow choking (V.R.Sanal Kumar et al., Physics of Fluids, Vol.33, No.3, 2021, DOI: 10.1063/5.0040440) are methodological advancements in predicting the deflagration-to-detonation-transition (DDT) in the real-world-fluid flows (continuum/non-continuum) with credibility.[1,2] Herein, we provide a proof of the concept of the Sanal-flow-choking and streamtube-flow-choking causing DDT in wall-bounded and free-external flows. Once the streamlines compacted, the considerable pressure difference attains inside the streamtube and the flow gets accelerated to the constricted region for satisfying the continuity condition set by the conservation law of nature. If the shape of the streamtube in the internal/external flow is similar to the convergent-divergent (CD) duct the phenomenon of the Sanal-flow-choking and supersonic flow development occurs at a critical-total-to-static pressure ratio (CPR) in yocto to yotta scale systems and beyond, which leads to shock wave generation or detonation as the case may me. At the lower critical detonation or hemorrhage index, the CPR of the reacting flow and the critical blood-pressure-ratio (BPR) of the subjects (human being/animal) are unique functions of the heat-capacity-ratio (HCR) of the evolved gas in the CD duct (V.R.Sanal Kumar et al., Global Challenges, Wiley Publication, January 2021, DOI: 10.1002/gch2.202000076, PMCID: PMC7933821; Sanal Kumar V.R et al. Stroke, Vol. 52, Issue Suppl_11 March 2021, doi.org/10.1161/str.52.suppl_1.P804). In silico results are presented herein to establish the proof of the concept of the Sanal-flow-choking and streamtube-flow-choking causing shock-wave/detonation in diabatic flow systems and asymptomatic-hemorrhagic-stroke in biological systems. The physics of detonation chemistry presented herein sheds light for exploring environmental and supernova explosions.[107] In silico results reported herein provide an authentic answer to many unresolved research questions in Physics in general and aerospace, mechanical, biological, chemical, energy, environmental, nano and material sciences in particular.


2021 ◽  
Author(s):  
Valsalayam Raghavapanicker Sanal Kumar ◽  
Shiv Kumar Choudhary ◽  
Pradeep Kumar Radhakrishnan ◽  
Rajaghatta Sundararam Bharath ◽  
Nichith Chandrasekaran ◽  
...  

The theoretical discovery of Sanal flow choking in the cardiovascular system (CVS) demands for interdisciplinary studies and universal actions to propose modern medications and to discover new drugs to annul the risk of flow-choking leading to shock-wave generation causing asymptomatic-cardiovascular-diseases. In this chapter we show that when blood-pressure-ratio (BPR) reaches the lower-critical-hemorrhage-index (LCHI) the flow-choking could occur in the CVS with and without stent. The flow-choking is uniquely regulated by the biofluid/blood-heat-capacity-ratio (BHCR). The BHCR is well correlated with BPR, blood-viscosity and ejection-fraction. The closed-form analytical models reveal that the relatively high and the low blood-viscosity are cardiovascular-risk factors. In vitro data shows that nitrogen, oxygen, and carbon dioxide gases are predominant in fresh blood samples of the human being/Guinea-pig at a temperature range of 37–40 °C (98.6–104 °F). In silico results demonstrate the occurrence of Sanal flow choking leading to shock wave generation and pressure-overshoot in CVS without any apparent occlusion. We could conclude authoritatively, without any ex vivo or in vivo studies, that the Sanal flow choking in CVS leads to asymptomatic-cardiovascular-diseases. The cardiovascular-risk could be diminished by concurrently lessening the viscosity of biofluid/blood and flow-turbulence by increasing the thermal-tolerance level in terms of BHCR and/or by decreasing the BPR.


2020 ◽  
Author(s):  
V R Sanal Kumar ◽  
Nichith Chandrasekaran ◽  
Vigneshwaran Sankar ◽  
Ajith Sukumaran ◽  
Sivabalan Mani ◽  
...  

Abstract The theoretical finding of the Sanal-flow-choking [PMCID: PMC7267099] is a methodological advancement in predicting the deflagration-to-detonation-transition (DDT) in the real-world-fluid flows (continuum/non-continuum) with credibility.[1,2] Herein, we provide a proof of the concept of the Sanal-flow-choking and streamtube-flow-choking causing DDT in wall-bounded and free-external flows. Once the streamlines compacted, the considerable pressure difference attains inside the streamtube and the flow gets accelerated to the constricted region for satisfying the continuity condition set by the conservation law of nature. If the shape of the streamtube in the internal/external flow is similar to the convergent-divergent (CD) duct the phenomenon of the Sanal-flow-choking and supersonic flow development occurs at a critical-total-to-static pressure ratio (CPR) in yocto to yotta scale systems and beyond, which leads to shock wave generation or detonation as the case may me. At the lower critical detonation or hemorrhage index, the CPR of the reacting flow and the critical blood-pressure-ratio (BPR) of the subjects (human being/animal) are unique functions of the heat-capacity-ratio (HCR) of the evolved gas in the CD duct. In silico results are presented herein to establish the proof of the concept of the Sanal-flow-choking and streamtube-flow-choking causing shock-wave/detonation in diabatic flow systems and asymptomatic-hemorrhagic-stroke in biological systems. The physics of detonation chemistry presented herein sheds light for exploring supernova explosions.[107]


2021 ◽  
Author(s):  
SANALKUMAR V R

Evidences are escalating on the diverse neurological disorders associated with COVID-19 pandemic due to the nanoscale Sanal flow choking (PMC7267099). The Sanal flow choking occurs at relatively high and low blood viscosity. Sanal flow choking leads to aneurysm, hemorrhagic-stroke and other neurological-disorders if the vessel geometry is having divergence, bifurcation, stenosis and/or occlusion regions (PMC7933821). Nanoscale Sanal flow choking is more susceptible at microgravity condition due to altered variations of blood viscosity, turbulence and the blood pressure ratio (BPR). Astronauts/Cosmonauts experienced neurological disorders during human spaceflight and thereafter. V.R.S.Kumar et al. (2021) reported that the asymptomatic episodes in the cardiovascular system are due to the internal flow choking (Biofluid/ Sanal flow choking) at a critical blood pressure ratio (BPR), which is regulated by the biofluid/blood heat capacity ratio (BHCR).  As the pressure of the nanoscale biofluid / non-continuum-flows rises, fluid viscosity increases and average-mean-free-path diminishes and thus, the Knudsen number lowers heading to a zero-slip wall-boundary condition with the compressible flow regime, which increases the risk of Sanal flow choking and the shock wave generation causing asymptomatic cardiovascular disease. Microgravity environment decreases plasma volume and increases the hematocrit compared with the situation on the Earth surface, which increases the relative viscosity of blood causing an early Sanal flow choking. Herein, we established that the disproportionate blood-thinning treatment increases the risk of the nanoscale Sanal flow choking due to the enhanced boundary-layer-blockage factor. The risk could be diminished by concurrently reducing the viscosity of biofluid/ blood and flow-turbulence by increasing the thermal-tolerance-level in terms of BHCR and/or by decreasing the BPR through new drug discovery or using companion medicine with the traditional blood thinners or other health care management. We recommend all astronauts/cosmonauts should wear ambulatory blood pressure and thermal level monitoring devices similar to a wristwatch throughout the space travel for the diagnosis, prognosis and prevention of internal flow choking leading to asymptomatic cardiovascular disease including neurological disorders.


2021 ◽  
Author(s):  
V. R. Sanal Kumar ◽  
Shiv Kumar Choudhary ◽  
Pradeep Kumar Radhakrishnan ◽  
R. S. Bharath ◽  
Nichith Chandrasekaran ◽  
...  

Abstract Herein, we established the proof of the concept of internal flow choking in CVS causing cardiovascular risk through the closed-form analytical, in vitro and in silico methods. An over dose of blood-thinning drug will enhance the Reynolds number, which creates high turbulence level causing an augmented boundary layer blockage factor leading to an early undesirable biofluid/Sanal flow choking at a critical blood-pressure-ratio (BPR). The fact is that in nanoscale vessels when the pressure of fluid increases, average-mean-free-path decreases and thus, the Knudsen number reduces. It leads to the physical situation of no-slip boundary condition with compressible-viscous flow effect. Sanal-flow-choking is a compressible-viscous flow effect establishing a physical condition of the sonic-fluid-throat, at a critical blood pressure ratio (BPR). We concluded that asymptomatic-hemorrhage (AH) and acute-heart-failure (AHF) are transient-events as a result of internal flow-choking in nanoscale and/or large vessels followed by the shock wave creation and transient pressure-overshoot. We concluded that cardiovascular risk could be reduced by simultaneously lessening the blood-viscosity and flow turbulence by increasing thermal-tolerance-level in terms of BHCR and/or by decreasing the blood pressure (BP) ratio.


Sign in / Sign up

Export Citation Format

Share Document